In August 2016, IPHARMA LLC was authorized by the Ministry of Healthcare of the Russian Federation to conduct the Phase I clinical trial of medicinal product ИД 4025. Protocol № HCV-ИД4025-04 «Double-blind randomized placebo-controlled study to evaluate...